Protein microarrays: Meeting analytical challenges for clinical applications

Cancer Cell - Tập 3 - Trang 317-325 - 2003
Lance A Liotta1, Virginia Espina1, Arpita I Mehta1,2, Valerie Calvert3, Kevin Rosenblatt1, David Geho1, Peter J Munson4, Lynn Young4, Julia Wulfkuhle3, Emanuel F Petricoin3
1FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
2NIH-Howard Hughes Research Scholar, Howard Hughes Medical Institute, Bethesda, MD 20892, USA
3FDA-NCI Clinical Proteomics Program, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
4Mathematical and Statistical Computing Laboratory, Center for Information Technology, National Institutes of Health, Bethesda, MD 20892 USA

Tài liệu tham khảo

Blume-Jensen, 2001, Oncogenic kinase signalling, Nature, 411, 355, 10.1038/35077225 Bobrow, 1989, Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays, J. Immunol. Methods, 125, 279, 10.1016/0022-1759(89)90104-X Bobrow, 1991, Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays, J. Immunol. Methods, 137, 103, 10.1016/0022-1759(91)90399-Z Bowden, 1999, An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation, Oncogene, 18, 4440, 10.1038/sj.onc.1202827 Brazma, 2001, Minimum information bout a microarray experiment (MIAME)—toward standars for microarray data, Nat. Genet., 29, 365, 10.1038/ng1201-365 Carlisle, 2000, Development of a prostate cDNA microarray and statistical gene expression analysis package, Mol. Carcinog., 28, 12, 10.1002/(SICI)1098-2744(200005)28:1<12::AID-MC3>3.0.CO;2-Q Celis, 2003, Proteomics in translational cancer research: Toward an integrated approach, Cancer Cell, 3, 9, 10.1016/S1535-6108(02)00242-8 Charboneau, 2002, Utility of reverse phase protein arrays: Applications to signaling pathways and human body arrays, Brief. Func. Genomics Proteomics, 1, 305, 10.1093/bfgp/1.3.305 Chen, 2002, Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors, Clin. Cancer Res., 8, 2298 Cutler, 2003, Protein arrays: The current state-of-the-art, Proteomics, 3, 3, 10.1002/pmic.200390007 Delehanty, 2002, A microarray immunoassay for simultaneous detection of proteins and bacteria, Anal. Chem., 74, 5681, 10.1021/ac025631l Emmert-Buck, 1996, Laser capture microdissection, Science, 274, 998, 10.1126/science.274.5289.998 Ge, 2000, UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions, Nucleic Acids Res., 28, e3, 10.1093/nar/28.2.e3 Greenbaum, 2002, Chemical approaches for functionally probing the proteome, Mol. Cell. Proteomics, 1, 60, 10.1074/mcp.T100003-MCP200 Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Hanash, 2003, Disease proteomics, Nature, 422, 226, 10.1038/nature01514 Huels, 2002, The impact of protein biochips and microarrays on the drug development process, Drug Discov. Today, 7, S119, 10.1016/S1359-6446(02)02389-9 Humphery-Smith, 2002, Protein arrays for assessment of target selectivity, Drug Discov. World, 4, 17 Hunter, 2000, Signaling–2000 and beyond, Cell, 100, 113, 10.1016/S0092-8674(00)81688-8 Hunyady, 1996, Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining, J. Histochem. Cytochem., 44, 1353, 10.1177/44.12.8985127 Ideker, 2001, Integrated genomic and proteomic analyses of a systematically perturbed metabolic network, Science, 292, 929, 10.1126/science.292.5518.929 Jeong, 2000, The large-scale organization of metabolic networks, Nature, 407, 651, 10.1038/35036627 Jessani, 2002, Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness, Proc. Natl. Acad. Sci. USA, 99, 10335, 10.1073/pnas.162187599 King, 1997, A highly sensitive detection method for immunohistochemistry using biotinylated tyramine, J. Pathol., 183, 237, 10.1002/(SICI)1096-9896(199710)183:2<237::AID-PATH893>3.0.CO;2-0 Knezevic, 2001, Proteomic profiling of the cancer microenvironment by antibody arrays, Proteomics, 1, 1271, 10.1002/1615-9861(200110)1:10<1271::AID-PROT1271>3.0.CO;2-6 Kukar, 2002, Protein microarrays to detect protein-protein interactions using red and green fluorescent proteins, Anal. Biochem., 306, 50, 10.1006/abio.2002.5614 Lal, 2002, Antibody arrays: an embryonic but rapidly growing technology, Drug Discov. Today, 7, S143, 10.1016/S1359-6446(02)02413-3 Liotta, 2001, The microenvironment of the tumour-host interface, Nature, 411, 375, 10.1038/35077241 Liotta, 2000, Molecular profiling of human cancer, Nat. Rev. Genet., 1, 48, 10.1038/35049567 Liotta, 2001, Clinical proteomics: personalized molecular medicine, JAMA, 286, 2211, 10.1001/jama.286.18.2211 MacBeath, 2002, Protein microarrays and proteomics, Nat. Genet., 32, 526, 10.1038/ng1037 MacBeath, 2000, Printing proteins as microarrays for high-throughput function determination, Science, 289, 1760, 10.1126/science.289.5485.1760 Miller, 2002, Optimal gene expression analysis by microarrays, Cancer Cell, 2, 353, 10.1016/S1535-6108(02)00181-2 Miller, 2003, Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers, Proteomics, 3, 56, 10.1002/pmic.200390009 Morozov, 2002, Direct detection of isotopically labeled metabolites bound to a protein microarray using a charge-coupled device, J. Biochem. Biophys. Methods, 51, 57, 10.1016/S0165-022X(01)00245-7 Pandey, 2000, Proteomics to study genes and genomes, Nature, 405, 837, 10.1038/35015709 Paweletz, 2001, Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front, Oncogene, 20, 1981, 10.1038/sj.onc.1204265 Petach, 2002, Dimensionality is the issue: use of photoaptamers in protein microarrays, Curr. Opin. Biotechnol., 13, 309, 10.1016/S0958-1669(02)00329-4 Petricoin, 2002, Clinical proteomics: translating benchside promise into bedside reality, Nat. Rev. Drug Discov., 1, 683, 10.1038/nrd891 Phizicky, 2003, Protein analysis on a proteomic scale, Nature, 422, 208, 10.1038/nature01512 Schaeferling, 2002, Application of self-assembly techniques in the design of biocompatible protein microarray surfaces, Electrophoresis, 23, 3097, 10.1002/1522-2683(200209)23:18<3097::AID-ELPS3097>3.0.CO;2-G Schweitzer, 2002, Multiplexed protein profiling on microarrays by rolling-circle amplification, Nat. Biotechnol., 20, 359, 10.1038/nbt0402-359 Seong, 2002, Microimmunoassay using a protein chip: optimizing conditions for protein immobilization, Clin. Diagn. Lab. Immunol., 9, 927 Simone, 2000, Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection, Am. J. Pathol., 156, 445, 10.1016/S0002-9440(10)64749-9 Sreekumar, 2001, Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins, Cancer Res., 61, 7585 Stillman, 2000, FAST slides: a novel surface for microarrays, Biotechniques, 29, 630, 10.2144/00293pf01 Templin, 2002, Protein microarray technology, Trends Biotechnol, 20, 160, 10.1016/S0167-7799(01)01910-2 Tyers, 2003, From genomics to proteomics, Nature, 422, 193, 10.1038/nature01510 Weng, 2002, Generating addressable protein microarrays with PROfusion covalent mRNA-protein fusion technology, Proteomics, 2, 48, 10.1002/1615-9861(200201)2:1<48::AID-PROT48>3.0.CO;2-I Wiese, 2003, Analysis of several fluorescent detector molecules for protein microarray use, Luminescence, 18, 25, 10.1002/bio.697 Wilson, 2003, Recent developments in protein microarray technology, Angew Chem. Int. Ed. Engl., 42, 494, 10.1002/anie.200390150 Zhu, 2001, Protein arrays and microarrays, Curr. Opin. Chem. Biol., 5, 40, 10.1016/S1367-5931(00)00170-8 Zhu, 2003, Protein chip technology, Curr. Opin. Chem. Biol., 7, 55, 10.1016/S1367-5931(02)00005-4